Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

It's not clear to me that the J&J vaccine's supply is large or critical enough that it's going to make that much of a difference (yet). If the supplies of the Moderna and Pfizer vaccines are such that most people with J&J appointments can just get one of the others instead, that's really not that big a deal.

Walk-ins might be affected, though, but I'm not sure what percentage of the total daily vaccinations are walk-ins vs. appointments.

And as a sibling mentions, the general risk of dying from COVID-19 is not 150 in 6M, because the probability of getting (symptomatic) COVID-19 needs to be factored into that figure. I would not be surprised that if that probability drops to under 1 in 6M after accounting for that, though of course the symptomatic infection risk differs based on demographics.

One thing that I am worried about, though, is that this might make people trust all the vaccines less in general. My girlfriend and I had J&J appointments for this Friday; fortunately we were able to get a walk-in Moderna shot today, but the issues with the J&J vaccine did give her a little anxiety even about the Moderna vaccine. I think that (and worse) might be pretty common, and isn't unreasonable.



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: